India Looks To Model New Central Drug Authority After U.S. FDA
This article was originally published in The Tan Sheet
Executive Summary
NEW DELHI - With elections to parliament slated for next year, India's Congress Party-led government is expected to pass a slew of bills in the pharmaceutical sector soon, including one establishing a central drug authority
You may also be interested in...
FDA in India
HHS Secretary Michael Leavitt and FDA Commissioner Andrew von Eschenbach are organizing teams to help advise the Indian government in creating its equivalent to FDA, Leavitt says Jan. 7 in a post to his blog. Leavitt offered the Indian Minister of Health and Family Welfare, Anbumani Ramadoss, technical assistance and discussed food and drug safety, he says. In September 2007, von Eschenbach worked with Chinese officials to finalize a memorandum on food, drug and medical device safety (1"The Tan Sheet" Sept. 24, 2007, In Brief)...
Indian Firms Look To Cash In On Growing Demand For Biosimilars
Dr. Reddy’s to introduce one new biosimilar a year, CEO vows.
Indian Bayh-Dole Evokes Mixed Reactions
Is a 1980s technology transfer solution from the U.S. a good fit for India?